Series A funding round for Obsidian Therapeutics raising $50M in December 2017
Series A funding round for Obsidian Therapeutics raising $50M in December 2017
| Investor | Firm Type | Partner |
|---|
GVLEAD | Venture Capital | — |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$330.5M
Top Valuation
-
Obsidian Therapeutics raised $50M in a Series A round.
The round was announced on 12/01/17.
The round was led by Blake Byers.